Načítá se...
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
BACKGROUND: To undertake an economic evaluation of rivaroxaban relative to the standard of care for stroke prevention in patients with non-valvular atrial fibrillation (AF) in Greece. METHODS: An existing Markov model designed to reflect the natural progression of AF patients through different healt...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3942277/ https://ncbi.nlm.nih.gov/pubmed/24512351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7547-12-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|